In an NCDB cohort of 536,783 breast radiation courses from 2020 to 2023, 5-fraction RT utilization rose from 4.3% to 17.4%, with overall 10.7% adoption across the 4-year period.
Pragya Jain
Advertisement
Articles by Pragya Jain
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Gedatolisib for HR+, HER2– PIK3CA Wild-Type Advanced Breast Cancer
2
Agenus Discontinues Phase 3 BATTMAN Trial in Metastatic MSS Colorectal Cancer
3
FDA Traditionally Approves Selpercatinib in RET+ Solid Tumors
4
Subcutaneous Isatuximab Could Ease Capacity Strain in Community Oncology
5